Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD018 as a Modulator of Irinotecan in Metastatic Colorectal Cancer
NCT00730158Phase 2Completed
- Start
- Dec 2008
- Primary completion
- Jun 2016
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 2 trial of PHY906 in colorectal cancer (CRC). Started Dec 2008; status: completed.
02
Drugs
PHY906
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00730158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730158.